Insider Transactions in Q4 2023 at Monopar Therapeutics (MNPR)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2023
|
Michael J Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,533
+1.06%
|
-
|
|
Dec 31
2023
|
Raymond Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,533
+8.62%
|
-
|
|
Dec 31
2023
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,469
-5.54%
|
$0
$0.34 P/Share
|
|
Dec 31
2023
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,474
+13.8%
|
-
|
|
Dec 31
2023
|
Christopher M Starr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,533
+8.92%
|
-
|
|
Dec 31
2023
|
Arthur J Klausner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,533
+7.58%
|
-
|
|
Dec 31
2023
|
Andrew Cittadine Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,098
-5.65%
|
$0
$0.34 P/Share
|
|
Dec 31
2023
|
Andrew Cittadine Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,952
+14.03%
|
-
|
|
Dec 31
2023
|
Kim R Tsuchimoto Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,073
-8.5%
|
$0
$0.34 P/Share
|
|
Dec 31
2023
|
Kim R Tsuchimoto Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,957
+17.2%
|
-
|